Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patients. | Front Allergy | 2023 | 37692891 | PubTator, text mining | PubMed |
| Calreticulin: a multifunctional protein with potential therapeutic applications for chronic wounds. | Front Med (Lausanne) | 2023 | 37692787 | PubTator, text mining | PubMed |
| Does molecular scarring in psoriasis exist? A review of the literature. | Postepy Dermatol Alergol | 2023 | 37692280 | PubTator, text mining | PubMed |
| Functions of the RIP kinase family members in the skin. | Cell Mol Life Sci | 2023 | 37688617 | PubTator, text mining | PubMed |
| Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis? | Int J Mol Sci | 2023 | 37686269 | PubTator, text mining | PubMed |
| The HPV8 E6 protein targets the Hippo and Wnt signaling pathways as part of its arsenal to restrain keratinocyte differentiation. | mBio | 2023 | 37676018 | PubTator, text mining | PubMed |
| Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients. | Front Cell Dev Biol | 2023 | 37675143 | PubTator, text mining | PubMed |
| Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia. | JCI Insight | 2023 | 37672481 | PubTator, text mining | PubMed |
| The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update. | Front Mol Biosci | 2023 | 37654796 | PubTator, text mining | PubMed |
| Identification and functional validation of SRC and RAPGEF1 as new direct targets of miR-203, involved in regulation of epidermal homeostasis. | Sci Rep | 2023 | 37635193 | PubTator, text mining | PubMed |
| Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling. | Molecules | 2023 | 37630370 | PubTator, text mining | PubMed |
| A Novel Multi-Component Formulation Reduces Inflammation In Vitro and Clinically Lessens the Symptoms of Chronic Eczematous Skin. | Int J Mol Sci | 2023 | 37629159 | PubTator, text mining | PubMed |
| Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. | JCI Insight | 2023 | 37561594 | PubTator, text mining | PubMed |
| Atopic dermatitis and gestational age - is there an association between them? A review of the literature and an analysis of pathology. | Postepy Dermatol Alergol | 2023 | 37545834 | PubTator, text mining | PubMed |
| Transplantation of human induced pluripotent stem cell derived keratinocytes accelerates deep second-degree burn wound healing. | World J Stem Cells | 2023 | 37545758 | PubTator, text mining | PubMed |
| S100 proteins in head and neck squamous cell carcinoma (Review). | Oncol Lett | 2023 | 37545618 | PubTator, text mining | PubMed |
| Dermal fibroblast cell-derived exosomes for atopic dermatitis: In-vitro test. | Skin Res Technol | 2023 | 37522488 | PubTator, text mining | PubMed |
| The Skin and Natural Cannabinoids-Topical and Transdermal Applications. | Pharmaceuticals (Basel) | 2023 | 37513960 | PubTator, text mining | PubMed |
| Anti-Inflammatory and Antiatopic Effects of Rorippa cantoniensis (Lour.) Ohwi in RAW 264.7 and HaCaT Cells. | Molecules | 2023 | 37513335 | PubTator, text mining | PubMed |
| The Anti-Inflammatory and Skin Barrier Function Recovery Effects of Schisandra chinensis in Mice with Atopic Dermatitis. | Medicina (Kaunas) | 2023 | 37512164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=13